Thymic 28-mer peptide for immunomodulation research.
Thymosin alpha-1 is a 28-amino-acid peptide derived from prothymosin alpha, used in research of T-cell maturation and innate-immune modulation.
Engages TLR2/TLR9 pathways and modulates dendritic-cell maturation, T-cell differentiation, and cytokine balance.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Tested Tα1 effects on dendritic cells and antifungal Th1 resistance.
Activated DC maturation and Th1-skewed response vs. control.
Reviewed Tα1 combined with cytokines/chemotherapy across cancers.
Documented improved response and tolerability signals across regimens.
Historical review of Tα1 use in chronic viral infection settings.
Cataloged evidence base supporting immune-restoration profile.
Lyophilized 2–8°C. Reconstituted: 2–8°C, 30 days.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — Thymosin Alpha-1 is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
